SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alfacell (ACEL)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1533 6 0 ACEL
Emcee:  Gil Kempenich Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
233 I dont believe we will find it was Shogen. She sells usually sells when optionsleighton stallones-1/23/1997
232 did anyone hear that it was Shogun who droped the 40,000 shares. Someone mentiGreg Kevorkian-1/23/1997
231 I dont see this as weakness,but still trying to recover from the ridiculous selleighton stallones-1/23/1997
230 Leighton, Any thoughts on the weakness here? GilGil Kempenich-1/23/1997
229 Isn't the Falkner report coming out any day now. By todays action I don'Greg Kevorkian-1/22/1997
228 What report are you anticipating, Greg?Gil Kempenich-1/22/1997
227 well we got some what of a move. Anticipation of the report coming out soon?Greg Kevorkian-1/21/1997
226 IPIC went as high as 43 in May/June. It is now 26.Gil Kempenich-1/17/1997
225 Yes Im familiar with McCamant ,he has seen some material on Alfacell in the pasleighton stallones-1/16/1997
224 Gil, out of curiosity how high did Interneuron get, and what is the stock pricGreg Kevorkian-1/16/1997
223 Leighton, I read an article recently, part of which follows. I'd like youGil Kempenich-1/16/1997
222 My regular mail? just did nothing new. I havent talked to him since Ive been hleighton stallones-1/15/1997
221 Leighton, check your E-Mail. Being in Austin do you have any direct contact witGCL-1/15/1997
220 I have also left Houston and moved to Austin which is a refreshing change. I bleighton stallones-1/15/1997
219 Hello, Leighton, Haven't talked to you since I left Houston. Good to haveGil Kempenich-1/15/1997
218 Your point is well taken. I,too, am familiar with this dark side of ACEL'sTom DuBois-1/15/1997
217 I have been following this company for over 10 years,even when they were listedleighton stallones-1/15/1997
216 John...an update on your issue of marginability. In discussions with Donna, thTom DuBois-1/14/1997
215 Tom, Thank you for your insightful reply. Obviously, you have followed this stoJon McHugh-1/14/1997
214 Jon No...I'm afraid I was a chicken too! I already feel a bit overextendedTom DuBois-1/14/1997
213 Gil/Folks - Most of the biotechs were down due to Amgen/Regeneron...Assume the Clouseau-1/14/1997
212 Thanks for the info, GCL. Just saw the following on the wire: "Amgen IncGil Kempenich-1/13/1997
211 CLINICAL TRIALS: If you want information about the clinical trials, (that have GCL-1/13/1997
210 Guess I was right on part of the assessment, even though I had no solid informaGil Kempenich-1/13/1997
209 I don't know if this is any news but the Falkner report will be coming outGreg Kevorkian-1/13/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):